Cargando…

A study to describe the health trajectory of patients with advanced renal disease who choose not to receive dialysis

BACKGROUND: Some patients with end-stage renal failure (ESRF) are unlikely to benefit from dialysis and conservative management (CM) is offered as a positive alternative. Understanding the trajectory of illness by health care professionals may improve end-of-life care. METHODS: We aimed to describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilshaw, Lindsey, Sammut, Hannah, Asher, Rebecca, Williams, Peter, Saxena, Rema, Howse, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886902/
https://www.ncbi.nlm.nih.gov/pubmed/27274835
http://dx.doi.org/10.1093/ckj/sfw005
_version_ 1782434663479902208
author Kilshaw, Lindsey
Sammut, Hannah
Asher, Rebecca
Williams, Peter
Saxena, Rema
Howse, Matthew
author_facet Kilshaw, Lindsey
Sammut, Hannah
Asher, Rebecca
Williams, Peter
Saxena, Rema
Howse, Matthew
author_sort Kilshaw, Lindsey
collection PubMed
description BACKGROUND: Some patients with end-stage renal failure (ESRF) are unlikely to benefit from dialysis and conservative management (CM) is offered as a positive alternative. Understanding the trajectory of illness by health care professionals may improve end-of-life care. METHODS: We aimed to describe the trajectory of functional status within our CM population through a prospective, observational study using the objective Timed Up and Go (TUG) test and subjective Barthel Index (BI) and health-related quality of life (HRQoL) [EuroQol 5D-5L (EQ-5D-5L)] measurements and correlating them with demographic and laboratory data and with sentinel events. RESULTS: There was a significant increase in TUG scores over the 6 months prior to death {2.24 [95% confidence interval (CI) 1.16–4.32], P = 0.017} and a significant decrease in EQ-5D-5L [−0.19 (95% CI −0.33 to −0.06), P = 0.006]. The only significant associations with mortality were serum albumin [hazard ratio (HR) 0.81 (95% CI 0.67–0.97), P = 0.024] and male gender [HR 5.94 (95% CI 1.50–23.5), P = 0.011]. CONCLUSIONS: We have shown there is a significant decline in functional status in the last 6 months before death in the CM population. Of interest, there was a significant relationship of lower serum albumin with functional decline and risk of death. We hope that with improved insight into disease trajectories we can improve our ability to identify and respond to the changes in needs of these patients, facilitate complex and sensitive end-of-life discussions and improve end-of-life care.
format Online
Article
Text
id pubmed-4886902
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-48869022016-06-03 A study to describe the health trajectory of patients with advanced renal disease who choose not to receive dialysis Kilshaw, Lindsey Sammut, Hannah Asher, Rebecca Williams, Peter Saxena, Rema Howse, Matthew Clin Kidney J End-Stage Kidney Disease BACKGROUND: Some patients with end-stage renal failure (ESRF) are unlikely to benefit from dialysis and conservative management (CM) is offered as a positive alternative. Understanding the trajectory of illness by health care professionals may improve end-of-life care. METHODS: We aimed to describe the trajectory of functional status within our CM population through a prospective, observational study using the objective Timed Up and Go (TUG) test and subjective Barthel Index (BI) and health-related quality of life (HRQoL) [EuroQol 5D-5L (EQ-5D-5L)] measurements and correlating them with demographic and laboratory data and with sentinel events. RESULTS: There was a significant increase in TUG scores over the 6 months prior to death {2.24 [95% confidence interval (CI) 1.16–4.32], P = 0.017} and a significant decrease in EQ-5D-5L [−0.19 (95% CI −0.33 to −0.06), P = 0.006]. The only significant associations with mortality were serum albumin [hazard ratio (HR) 0.81 (95% CI 0.67–0.97), P = 0.024] and male gender [HR 5.94 (95% CI 1.50–23.5), P = 0.011]. CONCLUSIONS: We have shown there is a significant decline in functional status in the last 6 months before death in the CM population. Of interest, there was a significant relationship of lower serum albumin with functional decline and risk of death. We hope that with improved insight into disease trajectories we can improve our ability to identify and respond to the changes in needs of these patients, facilitate complex and sensitive end-of-life discussions and improve end-of-life care. Oxford University Press 2016-06 2016-03-24 /pmc/articles/PMC4886902/ /pubmed/27274835 http://dx.doi.org/10.1093/ckj/sfw005 Text en © The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle End-Stage Kidney Disease
Kilshaw, Lindsey
Sammut, Hannah
Asher, Rebecca
Williams, Peter
Saxena, Rema
Howse, Matthew
A study to describe the health trajectory of patients with advanced renal disease who choose not to receive dialysis
title A study to describe the health trajectory of patients with advanced renal disease who choose not to receive dialysis
title_full A study to describe the health trajectory of patients with advanced renal disease who choose not to receive dialysis
title_fullStr A study to describe the health trajectory of patients with advanced renal disease who choose not to receive dialysis
title_full_unstemmed A study to describe the health trajectory of patients with advanced renal disease who choose not to receive dialysis
title_short A study to describe the health trajectory of patients with advanced renal disease who choose not to receive dialysis
title_sort study to describe the health trajectory of patients with advanced renal disease who choose not to receive dialysis
topic End-Stage Kidney Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886902/
https://www.ncbi.nlm.nih.gov/pubmed/27274835
http://dx.doi.org/10.1093/ckj/sfw005
work_keys_str_mv AT kilshawlindsey astudytodescribethehealthtrajectoryofpatientswithadvancedrenaldiseasewhochoosenottoreceivedialysis
AT sammuthannah astudytodescribethehealthtrajectoryofpatientswithadvancedrenaldiseasewhochoosenottoreceivedialysis
AT asherrebecca astudytodescribethehealthtrajectoryofpatientswithadvancedrenaldiseasewhochoosenottoreceivedialysis
AT williamspeter astudytodescribethehealthtrajectoryofpatientswithadvancedrenaldiseasewhochoosenottoreceivedialysis
AT saxenarema astudytodescribethehealthtrajectoryofpatientswithadvancedrenaldiseasewhochoosenottoreceivedialysis
AT howsematthew astudytodescribethehealthtrajectoryofpatientswithadvancedrenaldiseasewhochoosenottoreceivedialysis
AT kilshawlindsey studytodescribethehealthtrajectoryofpatientswithadvancedrenaldiseasewhochoosenottoreceivedialysis
AT sammuthannah studytodescribethehealthtrajectoryofpatientswithadvancedrenaldiseasewhochoosenottoreceivedialysis
AT asherrebecca studytodescribethehealthtrajectoryofpatientswithadvancedrenaldiseasewhochoosenottoreceivedialysis
AT williamspeter studytodescribethehealthtrajectoryofpatientswithadvancedrenaldiseasewhochoosenottoreceivedialysis
AT saxenarema studytodescribethehealthtrajectoryofpatientswithadvancedrenaldiseasewhochoosenottoreceivedialysis
AT howsematthew studytodescribethehealthtrajectoryofpatientswithadvancedrenaldiseasewhochoosenottoreceivedialysis